160 related articles for article (PubMed ID: 3400679)
1. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Mortimer J; Miller S; Black D; Kwok K; Kirby WM
Am J Med; 1988 Jul; 85(1A):17-20. PubMed ID: 3400679
[TBL] [Abstract][Full Text] [Related]
2. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
[TBL] [Abstract][Full Text] [Related]
3. Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.
Jones P; Bodey GP; Rolston K; Fainstein V; Riccardi S
Am J Med; 1988 Jul; 85(1A):3-8. PubMed ID: 3400680
[TBL] [Abstract][Full Text] [Related]
4. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
[TBL] [Abstract][Full Text] [Related]
5. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
Baruchel A; Hartmann O; Andremont A; Tancrède C
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
[TBL] [Abstract][Full Text] [Related]
6. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
[TBL] [Abstract][Full Text] [Related]
7. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
Liang R; Yung R; Chiu E; Chau PY; Chan TK; Lam WK; Todd D
Antimicrob Agents Chemother; 1990 Jul; 34(7):1336-41. PubMed ID: 2201252
[TBL] [Abstract][Full Text] [Related]
8. Imipenem-cilastatin as initial therapy for febrile cancer patients.
Bodey GP; Alvarez ME; Jones PG; Rolston KV; Steelhammer L; Fainstein V
Antimicrob Agents Chemother; 1986 Aug; 30(2):211-4. PubMed ID: 3532942
[TBL] [Abstract][Full Text] [Related]
9. [Imipenem/cilastatin as monotherapy in neutropenic patients with fever].
Fridrik MA; Wahl G; Grafinger-Witt E; Leisch F
Wien Med Wochenschr; 1988 Nov; 138(21):548-51. PubMed ID: 3201783
[TBL] [Abstract][Full Text] [Related]
10. Imipenem/cilastatin therapy for serious infections in neonates and infants.
Nalin DR; Jacobsen CA
Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
[TBL] [Abstract][Full Text] [Related]
11. Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Ozyilkan O; Yalçintaş U; Başkan S
Korean J Intern Med; 1999 Jul; 14(2):15-9. PubMed ID: 10461420
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
Pegram PS; Phair JP; McMahan R; Murphy RL; Gordon LI; Washton H; Faubion C; Saviteer S; Cohen MS
J Antimicrob Chemother; 1989 Oct; 24(4):591-604. PubMed ID: 2693432
[TBL] [Abstract][Full Text] [Related]
13. Imipenem: a new carbapenem antibiotic.
Lipman B; Neu HC
Med Clin North Am; 1988 May; 72(3):567-79. PubMed ID: 3280907
[TBL] [Abstract][Full Text] [Related]
14. Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
Winston DJ; Ho WG; Bruckner DA; Champlin RE
Ann Intern Med; 1991 Dec; 115(11):849-59. PubMed ID: 1952471
[TBL] [Abstract][Full Text] [Related]
15. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R
Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230
[TBL] [Abstract][Full Text] [Related]
16. Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
Arnold HM; McKinnon PS; Augustin KM; Hladnik LM; Casabar E; Reichley RM; Dubberke ER; Westervelt P; Ritchie DJ
Pharmacotherapy; 2009 Aug; 29(8):914-23. PubMed ID: 19637944
[TBL] [Abstract][Full Text] [Related]
17. Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients.
Shah PM; Heller A; Fuhr HG; Walther F; Halir S; Schaumann R; Böhme A; Jung B; Köhler A; Lips-Schulte C; Stille W
Infection; 1996; 24(6):480-4. PubMed ID: 9007599
[TBL] [Abstract][Full Text] [Related]
18. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
[TBL] [Abstract][Full Text] [Related]
19. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
Calandra G; Lydick E; Carrigan J; Weiss L; Guess H
Am J Med; 1988 May; 84(5):911-8. PubMed ID: 3284342
[TBL] [Abstract][Full Text] [Related]
20. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.
Karadeniz C; Oğuz A; Canter B; Serdaroğlu A
Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
